Why the study?
Does resection of metastases improve disease-free survival in patients with extremity soft-tissue sarcomas who develop metastatic disease?
Does resection of metastases improve disease-free survival in patients with extremity soft-tissue sarcomas who develop metastatic disease?
Resection of isolated pulmonary metastases or local recurrences can result in disease-free survival for a select subset of patients with extremity soft-tissue sarcomas.
Answers are grounded in this paper and cite their sources.
May support selective resection of isolated pulmonary metastases in extremity soft-tissue sarcoma; leaves open need for randomized trials to confirm benefit.
This study examines recurrence patterns in 255 patients with soft-tissue sarcoma treated with preoperative chemotherapy and radiation, followed by limb-sparing surgery. Eighty-five patients developed metastatic disease: 13 had isolated local recurrence, 43 had isolated pulmonary metastases, 11 had metastases to lung and elsewhere, and 18 had metastases to multiple sites. Of the patients with isolated pulmonary metastases, 19/43 had resection of the metastases, and 9 are disease free. All 13 patients with local recurrences had resection of the recurrence, and 9 remain disease-free. Patients with multiple sites of recurrence had a 2-year survival of less than 10%. Resection of metastases is beneficial to a small number of patients who develop metastatic disease.
No takes yet. Share an insight, caveat, or question.
Huth et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: